ReP USP - Resultado da busca

Artigo de periodico
Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? (2014)
Neves, Karla Bianca; Lobato, Núbia S; Lopes, Rhéure Alves Moreira; Filgueira, Fernando P; Zanotto, Camila Ziliotto; Oliveira, Ana Maria de; Tostes, Rita de Cassia Aleixo
Source: Clinical Science. Unidades: FCFRP, FMRP
Subjects: ACETILCOLINA (FARMACOLOGIA), AORTA TORÁCICA (EFEITOS DE DROGAS), ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Karla Bianca et al. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?. Clinical Science, v. 127, n. 2, p. 111-122, 2014Tradução . . Disponível em: https://doi.org/10.1042/CS20130286. Acesso em: 05 nov. 2024.
APA
Neves, K. B., Lobato, N. S., Lopes, R. A. M., Filgueira, F. P., Zanotto, C. Z., Oliveira, A. M. de, & Tostes, R. de C. A. (2014). Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? Clinical Science, 127( 2), 111-122. doi:10.1042/CS20130286
NLM
Neves KB, Lobato NS, Lopes RAM, Filgueira FP, Zanotto CZ, Oliveira AM de, Tostes R de CA. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? [Internet]. Clinical Science. 2014 ; 127( 2): 111-122.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1042/CS20130286
Vancouver
Neves KB, Lobato NS, Lopes RAM, Filgueira FP, Zanotto CZ, Oliveira AM de, Tostes R de CA. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? [Internet]. Clinical Science. 2014 ; 127( 2): 111-122.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1042/CS20130286
Artigo de periodico
Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta (2011)
Choi, Hyehun; Tostes, Rita de Cassia Aleixo; Webb, Clinton
Source: Journal of Cardiovascular Pharmacology. Unidade: FMRP
Subjects: ACETOFENONAS, ANTIOXIDANTES (FARMACOLOGIA), AORTA TORÁCICA (EFEITOS DE DROGAS), INIBIDORES DE ENZIMAS, PERÓXIDO DE HIDROGÊNIO (METABOLISMO), ESTRESSE OXIDATIVO, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHOI, Hyehun e TOSTES, Rita de Cassia Aleixo e WEBB, Clinton. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta. Journal of Cardiovascular Pharmacology, v. 58, n. 5, p. 522-527, 2011Tradução . . Disponível em: https://doi.org/10.1097/FJC.0b013e31822d80a5. Acesso em: 05 nov. 2024.
APA
Choi, H., Tostes, R. de C. A., & Webb, C. (2011). Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta. Journal of Cardiovascular Pharmacology, 58( 5), 522-527. doi:10.1097/FJC.0b013e31822d80a5
NLM
Choi H, Tostes R de CA, Webb C. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 5): 522-527.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/FJC.0b013e31822d80a5
Vancouver
Choi H, Tostes R de CA, Webb C. Thioredoxin reductase inhibition reduces relaxation by increasing oxidative stress and S-nitrosylation in mouse aorta [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 5): 522-527.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/FJC.0b013e31822d80a5
Artigo de periodico
Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis (2011)
Montenegro, Marcelo Freitas; Ceron, Carla S.; Salgado, Maria Cristina Oliveira; Desta, Zeruesenay; Flockhart, David A.; Tanus-Santos, José Eduardo
Source: Journal of Cardiovascular Pharmacology. Unidade: FMRP
Subjects: TIPO DE COBAIA UTILIZADA NO TRABALHO DE PESQUISA : RATOS WISTAR, ANTINEOPLÁSICOS (FARMACOLOGIA), AORTA TORÁCICA (EFEITOS DE DROGAS), ESTRADIOL (ANÁLOGOS E DERIVADOS), PROSTAGLANDINAS (BIOSSÍNTESE), VASODILATAÇÃO (EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTENEGRO, Marcelo Freitas et al. Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis. Journal of Cardiovascular Pharmacology, v. 58, n. 6, p. 647-653, 2011Tradução . . Disponível em: https://doi.org/10.1097/FJC.0b013e31823171ba. Acesso em: 05 nov. 2024.
APA
Montenegro, M. F., Ceron, C. S., Salgado, M. C. O., Desta, Z., Flockhart, D. A., & Tanus-Santos, J. E. (2011). Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis. Journal of Cardiovascular Pharmacology, 58( 6), 647-653. doi:10.1097/FJC.0b013e31823171ba
NLM
Montenegro MF, Ceron CS, Salgado MCO, Desta Z, Flockhart DA, Tanus-Santos JE. Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 6): 647-653.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/FJC.0b013e31823171ba
Vancouver
Montenegro MF, Ceron CS, Salgado MCO, Desta Z, Flockhart DA, Tanus-Santos JE. Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesis [Internet]. Journal of Cardiovascular Pharmacology. 2011 ; 58( 6): 647-653.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/FJC.0b013e31823171ba

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em